Sirolimus + early ciclosporin withdrawal good value in renal transplant Clinical study 02 February 2013 Pages: 1 - 1
Strategies for positive prevention of HIV infections that prioritise interventions for patients with HIV can help reduce the risk of HIV transmission in Africa, Comment 02 February 2013 Pages: 2 - 2
Peginterferon-α and ribavirin have been recommended for the treatment of mild chronic hepatitis C, Media release 02 February 2013 Pages: 2 - 2
Ezetimibe add-on to atorvastatin: evidence for adoption in Canada Clinical study 02 February 2013 Pages: 3 - 3
Access to drug-eluting stents (DES) is influenced by factors such as demographics, hospital characteristics and socioeconomics, Clinical study 02 February 2013 Pages: 4 - 4
Intensive treatment with high-dose atorvastatin is cost effective in the secondary prevention of coronary heart disease (CHD) in the UK, Clinical study 02 February 2013 Pages: 4 - 4
Calcineurin inhibitor (CNI)-free immunosuppressant regimens appear to be cost saving over CNI-containing regimens in renal transplant recipients, Clinical study 02 February 2013 Pages: 4 - 4
Inflammatory bowel disease: not all costs are equal in Germany Clinical study 02 February 2013 Pages: 5 - 5
Joint crisis plans for the management of psychotic disorders are probably more cost effective than standardised service information, Clinical study 02 February 2013 Pages: 5 - 5
Omega-3 ethylester concentrate a worthy addition for MI prevention Clinical study 02 February 2013 Pages: 7 - 7
Nonbranded ciclosporin use appears to be associated with increased healthcare costs due to higher pharmacy and inpatient utilisation Clinical study 02 February 2013 Pages: 7 - 7
Oral chemotherapy saves money in metastatic colorectal cancer Clinical study 02 February 2013 Pages: 8 - 8
Substantial cost savings can result from the use of losartan in patients with type 2 diabetes mellitus (T2DM) and nephropathy, Clinical study 02 February 2013 Pages: 8 - 8
The use of once-weekly epoetin-α has no effect on health-related quality of life (HRQOL) in children with cancer,* Clinical study 02 February 2013 Pages: 9 - 9
Serotonergic role in cognitive/social effects of atypicals Clinical study 02 February 2013 Pages: 9 - 9
Etanercept is likely to be cost effective in the UK for plaque psoriasis when used in accordance with treatment guidelines, Clinical study 02 February 2013 Pages: 9 - 9
Most of the new regulations stemming from Bill 102, the Transparent Drug System for Patients Act 2006, previously approved by the Ontario government in Canada, will soon come into effect, News item 02 February 2013 Pages: 10 - 10
A decision to fund paclitaxel [Taxol] for node-positive early breast cancer from 1 September 2006 will give breast cancer treatments a boost in New Zealand, Media release 02 February 2013 Pages: 10 - 10
President Bush has called for greater transparency in US healthcare, News item 02 February 2013 Pages: 11 - 11
Enfuvirtide [Fuzeon] will be funded for New Zealand patients with HIV infections/AIDS, Media release 02 February 2013 Pages: 11 - 11